Evidence map›Paper›PMID 38504544›Full record

Trial reportJournal of traditional Chinese medicine = Chung i tsa chih ying wen pan2024

Effectiveness and safety of Qidong Huoxue decoction in treatment of acute lung injury and acute respiratory distress syndrome: a randomized, controlled trial.

Y U Zhengqiu, Y U Liuda, Chen Ye, L I Mingjing, Cai Wanru

Open access · greenAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Y U ZhengqiuSchool of Medicine, Xiamen University, Xiamen 361005, China.
Y U Liudathe Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Chen YeDepartment of Respiratory Medical, the Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310005, China.
L I MingjingDepartment of Respiratory Medical, the Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310005, China.
Cai WanruDepartment of Respiratory Medical, the Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310005, China.
Xiamen University · CNZhejiang Chinese Medical University · CN

Funding

Zhejiang Province Traditional Chinese Medicine Science and Technology Plan: the Study on Clinical Effects of Qidong Huoxue decoction in the Treatment of Acute Lung Injury 2017ZZ008
6 · The paper itself

Abstract

objectiveTo evaluate the efficacy of Qidong Huoxue decoction (，QDHX) in treating acute lung injury and acute respiratory distress syndrome (ALI/ARDS) when used as an adjunctive treatment.

methodsALI/ARDS patients admitted to our medical intensive care unit were randomly allocated to the control group or the QDHX group and received standard therapy. The QDHX group received QDHX (50 mL per day for 14 d) orally or

resultsA total of 73 patients completed the study (36 in the TCM and 37 in the conventional group), and their records were analyzed. After 14-d treatment, the TCM group showed a significant decrease in TCM syndrome scores (

conclusionsOur study results show that QDHX in combination with conventional drug therapy can significantly reduce some clinical symptoms in patients with ALI/ARDS.

Indexed as

Acute Lung InjuryRespiratory Distress SyndromeHumansIntensive Care UnitsOxygenOxygenacute lung injuryQidong Huoxue decoctionrandomized controlled trialrespiratory distress syndrome

Identifiers

PMID38504544
PMCPMC10927401
OpenAlexW4394738462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.